Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Pharmacological modification of dendritic cells to promote their tolerogenicity in transplantation.

Turnquist HR, Fischer RT, Thomson AW.

Methods Mol Biol. 2010;595:135-48. doi: 10.1007/978-1-60761-421-0_8.

PMID:
19941109
2.
3.

Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.

Horibe EK, Sacks J, Unadkat J, Raimondi G, Wang Z, Ikeguchi R, Marsteller D, Ferreira LM, Thomson AW, Lee WP, Feili-Hariri M.

Transpl Immunol. 2008 Feb;18(4):307-18. Epub 2007 Nov 5.

PMID:
18158116
4.

Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.

Ikeguchi R, Sacks JM, Unadkat JV, Solari M, Horibe EK, Thomson AW, Lee AW, Feili-Hariri M.

Transplantation. 2008 Jan 27;85(2):237-46. doi: 10.1097/TP.0b013e31815e870e.

PMID:
18212629
5.

Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival.

Taner T, Hackstein H, Wang Z, Morelli AE, Thomson AW.

Am J Transplant. 2005 Feb;5(2):228-36.

6.

Use of rapamycin in the induction of tolerogenic dendritic cells.

Fischer R, Turnquist HR, Taner T, Thomson AW.

Handb Exp Pharmacol. 2009;(188):215-32. doi: 10.1007/978-3-540-71029-5_10. Review.

PMID:
19031028
7.

Dendritic cells in transplant tolerance.

Nouri-Shirazi M.

Iran J Immunol. 2007 Mar;4(1):1-14. Review.

8.

Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation.

Turnquist HR, Thomson AW.

Curr Opin Organ Transplant. 2008 Aug;13(4):350-7. doi: 10.1097/MOT.0b013e328306116c. Review.

PMID:
18685329
9.

Dendritic cells,tolerance and therapy of organ allograft rejection.

Raimondi G, Thomson AW.

Contrib Nephrol. 2005;146:105-20. Review.

PMID:
15567925
10.

Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation.

Liu Y, Chen Y, Liu FQ, Lamb JR, Tam PK.

Transpl Int. 2008 May;21(5):483-94. doi: 10.1111/j.1432-2277.2007.00630.x. Epub 2008 Feb 4.

11.

Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.

Zhang X, Li M, Lian D, Zheng X, Zhang ZX, Ichim TE, Xia X, Huang X, Vladau C, Suzuki M, Garcia B, Jevnikar AM, Min WP.

Clin Immunol. 2008 Jun;127(3):313-21. doi: 10.1016/j.clim.2008.01.013. Epub 2008 Mar 20.

PMID:
18358783
12.
13.

Dendritic cells as promoters of transplant tolerance.

Nouri-Shirazi M, Thomson AW.

Expert Opin Biol Ther. 2006 Apr;6(4):325-39. Review.

PMID:
16548761
14.

Rapamycin-conditioned dendritic cells activated with monophosphoryl lipid-A promote allograft acceptance in vivo.

Campos-Acuña J, Pérez F, Narváez E, Campos-Mora M, Gajardo T, Catalán D, Aguillón JC, Pino-Lagos K.

Immunotherapy. 2015;7(2):101-10. doi: 10.2217/imt.14.116.

PMID:
25713986
15.

Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.

Kuo YR, Huang CW, Goto S, Wang CT, Hsu LW, Lin YC, Yang KD, Chen CL, Lee WP.

J Surg Res. 2009 May 15;153(2):317-25. doi: 10.1016/j.jss.2008.05.034. Epub 2008 Jun 25.

PMID:
19101689
16.

Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance.

Ge W, Jiang J, Baroja ML, Arp J, Zassoko R, Liu W, Bartholomew A, Garcia B, Wang H.

Am J Transplant. 2009 Aug;9(8):1760-72. doi: 10.1111/j.1600-6143.2009.02721.x. Epub 2009 Jun 26.

17.

The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.

Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C, Zhao Y.

Transpl Immunol. 2007 Apr;17(3):153-61. Epub 2007 Jan 24.

PMID:
17331841
18.

Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus.

Tao R, Wang L, Chen CH, Wang SH, Demarco RA, Lotze MT, Thai NL, Fung JJ, Lu L, Qian S.

J Heart Lung Transplant. 2006 Mar;25(3):310-9. Epub 2006 Jan 25.

PMID:
16507425
19.

Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages.

Woltman AM, de Fijter JW, Kamerling SW, van Der Kooij SW, Paul LC, Daha MR, van Kooten C.

Blood. 2001 Jul 1;98(1):174-80.

20.

Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction.

Fedoric B, Krishnan R.

Immunol Lett. 2008 Oct 30;120(1-2):49-56. doi: 10.1016/j.imlet.2008.06.009. Epub 2008 Jul 22.

PMID:
18652845

Supplemental Content

Support Center